Justice Department Intervenes in Texas Medicaid Fraud Case Against Planned Parenthood

The U.S. Justice Department has officially entered a multi-year legal dispute in Texas, taking a direct role in a lawsuit that accuses Planned Parenthood of Medicaid fraud. This intervention, formalized in a court filing, marks a significant shift in federal involvement regarding the case, which was originally championed by outgoing Republican Texas Attorney General Ken Paxton. The lawsuit alleges that the reproductive health organization violated the federal False Claims Act by continuing to bill and collect Medicaid payments after the state moved to terminate its funding.

At the heart of the litigation is a demand for the repayment of funds collected from Medicaid programs in Texas and Louisiana, alongside substantial financial penalties. Estimates suggest the total judgment sought could reach approximately $1.8 billion. Planned Parenthood has consistently maintained that its billing practices were lawful during the period when state termination decisions were paused by court orders, arguing that it cannot be held liable for providing legal guidance to its affiliates.

The timing of the Justice Department's move has drawn significant attention, occurring shortly after Texas voters elected Democrat Nathan Johnson as the state's next attorney general. Johnson has previously expressed intentions to review various lawsuits initiated during Paxton’s tenure, leading some observers to suggest that the federal intervention serves to ensure the case continues regardless of potential shifts in state-level legal strategy. Planned Parenthood representatives have characterized the federal government's involvement as a deliberate effort to force the organization out of business.

Following a nearly three-year hiatus, the case is moving forward after the U.S. 5th Circuit Court of Appeals ruled that previous attempts to dismiss the litigation were premature. With the federal government now a party to the suit, the legal pressure on the organization has intensified. The case is currently slated for a potential trial in the spring of 2027, and the outcome remains a critical concern for the future of reproductive health services in the region.